{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:33:44Z","timestamp":1791380024460,"version":"4.3.3"},"reference-count":37,"publisher":"MedWorks Media","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacol Bull"],"abstract":"<jats:p>Objectives\nHyperactive intracellular calcium ion concentration ([Ca 2+ ] i ) in peripheral cells of patients with bipolar disorder has been reported repeatedly. Reduction of intracellular calcium ion concentration has been found with the established mood stabilizers lithium and carbamazepine, but less reliably with valproate. This study examined whether inconsistent findings with valproate could be a function of the subjects studied.\nExperimental design\nPlatelet [Ca 2+ ] i at baseline ([Ca 2+ ] B ) and after stimulation with thrombin and platelet activating factor ([Ca 2+ ] S ) was measured with and without incubation with therapeutic levels of valproate in mildly to moderately ill bipolar disorder patients (N = 14).\nPrincipal observations\nPrior to incubation with valproate, platelet [Ca 2+ ] B and [Ca 2+ ] S were generally lower than has been reported in studies of intracellular calcium ion concentration in bipolar disorder, consistent with at most moderate symptom severity and impairment. Incubation with valproate raised [Ca 2+ ] B somewhat, primarily in patients with lower initial [Ca 2+ ] B . Valproate incubation blunted the increase in [Ca 2+ ] i with platelet stimulation, but valproate did not alter final [Ca 2+ ] S , reflecting a smaller increase with valproate but a higher starting point (i.e., [Ca 2+ ] B ) in valproate incubated cells.\nConclusions\nMixed results of studies of cellular actions of valproate on intracellular calcium signaling may be the results of use of subjects with milder illness and normal baseline signaling. Studies of animals and normal human subjects may be less informative about the potential mechanism of action of any psychotropic medication than studies of patients with sufficient severity of illness and abnormalities in the dimension of cellular function targeted by the medication.<\/jats:p>","DOI":"10.64719\/pb.4550","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:23:34Z","timestamp":1761045814000},"page":"24-35","source":"Crossref","is-referenced-by-count":2,"title":["Effects of Valproate on Intracellular Calcium Ion Signaling: Implications for Mechanistic Research"],"prefix":"10.64719","volume":"55","author":[{"given":"Steven L","family":"Dubovsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Daurignac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevie","family":"Kandefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54175","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"van Calker D, Forstner U, Bohus M et al. Increased sensitivity to agonist stimulation of the Ca2+ response in neutrophils of manic-depressive patients: effect of lithium therapy. Neuropsychobiology. 1993;27:180\u2013183.","DOI":"10.1159\/000118977"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Hahn CG, Gomez G, Restrepo D et al. Aberrant intracellular calcium signaling in olfactory neurons from patients with bipolar disorder. Am J Psychiatry. 2005;162:616\u2013618.","DOI":"10.1176\/appi.ajp.162.3.616"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Kato T. Molecular neurobiology of bipolar disorder: a disease of \u201cmood-stabilizing neurons\u201d? Trends in Neuroscience. 2008;31:495\u2013503.","DOI":"10.1016\/j.tins.2008.07.007"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Dubovsky SL, Christiano J, Daniell LC. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. ArchGenPsychiatry. 1989;46:632\u2013638.","DOI":"10.1001\/archpsyc.1989.01810070058010"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Dubovsky SL, Daurignac E, Leonard KE, Serotte JC. Levetiracetam, calcium antagonism, and bipolar disorder. J Clin Psychopharmacology. 2015;35:422\u2013427.","DOI":"10.1097\/JCP.0000000000000343"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Dubovsky SL, Lee C, Christiano J. Elevated intracellular calcium ion concentration in bipolar depression. BiolPsychiatry. 1991;29:441\u2013450.","DOI":"10.1016\/0006-3223(91)90266-O"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Dubovsky SL, Murphy J, Thomas M, Rademacher J. Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. Am J Psychiatry. 1992;149(1):118\u2013120.","DOI":"10.1176\/ajp.149.1.118"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Dubovsky SL, Murphy J, Christiano J, Lee C. The calcium second messenger system in bipolar disorders: data supporting new research directions. Journal of Neuropsychiatry and Clinical Neurosciences. 1992;4:3\u201314.","DOI":"10.1176\/jnp.4.1.3"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Dubovsky SL, Thomas M, Hijazi A, Murphy J. Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder. Eur Arch Psychiatry Clin Neurosci. 1994;243(5):229\u2013234.","DOI":"10.1007\/BF02191579"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Dubovsky SL, Daurignac E, Leonard KE. Increased platelet intracellular calcium ion concentration is specific to bipolar disorder. J Affective Disord. 2014;164:38\u201342. doi: 10.1016\/j.jad.2014.04.025.","DOI":"10.1016\/j.jad.2014.04.025"},{"key":"ref11","unstructured":"Dubovsky SL, Lee C, Christiano J. Lithium decreases platelet intracellular calcium ion concentrations in bipolar patients. Lithium. 1991;2:167\u2013174."},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Okuma T, Kishimoto A. A history of investigation on the mood stabilizing effect of carbamazepine in Japan. Psychiatry & Clinical Neurosciences. 1998;52:3\u201312.","DOI":"10.1111\/j.1440-1819.1998.tb00966.x"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Walden J, Grunze H, Bungmann D, Liu Z, Dusing R. Calcium antagonist effects of carbamazeine as a mechanism of action in neuropsychiatric disorders. Studies in calcium dependent model epilepsies. European Neuopsychopharmacol. 1992;2:455\u2013462.","DOI":"10.1016\/0924-977X(92)90009-W"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Walden J, Grunze H, Mayer A et al. Calcium antagonistic effects of carbamazepine in epilepsies and affective psychoses. Neuropsychobiology. 1993;27:171\u2013175.","DOI":"10.1159\/000118975"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Bowden C, Calabrese JR, McElroy SL et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex maintenance study group. Arch Gen Psychiatry. 2000;57:481\u2013489.","DOI":"10.1001\/archpsyc.57.5.481"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Kazuno A, Munakata K, Kato N, Kato T. Mitochondrial DNA-dependent effects of valproate on mitochondrial calcium levels in transmitochondrial cybrids. Int J Neuropsychopharmacol. 2008;11:71\u201378.","DOI":"10.1017\/S1461145707007614"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Shao L, Young LT, Wang JF. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol Psychiatry. 2005;58:879\u2013884.","DOI":"10.1016\/j.biopsych.2005.04.052"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Cinzia C, Martella G, Picconi B et al. Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. Stroke. 2006;37:1319\u20131326.","DOI":"10.1161\/01.STR.0000217303.22856.38"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Raganacova D, Jahn K, Kotsiari A et al. Analysis of neuroprotective effects of valproic acid on primary motor neurons in monoculture of co-cultures with astrocytes or Schwann cells. Cell Mol Neurobiol. 2009;29:1037\u20131043.","DOI":"10.1007\/s10571-009-9393-3"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Perova T, Kwan M, Li PP, Warsh JJ. Differential modulation of intracellular Ca2+ responses in B lymphoblasts by mood stabilizers. International Journal of Neuropsychopharmacology. 2010;13:693\u2013702.","DOI":"10.1017\/S1461145709000261"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Ulrich ML, Rotzinger S, Asghar SJ. Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels. Rev Psychiatr Neurosci. 2003;28(2):116\u2013125.","DOI":"10.1139\/jpn.0313"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Manaka K, Nakata M, Shimomura K et al. Chronic exposure to valproic acid promotes insulin release, reduces KATP channel current and does not affect Ca2+ signaling in mouse islets. J Physiol Sci. 2014;64:77\u201383.","DOI":"10.1007\/s12576-013-0294-3"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Costa C, Martella G, Picconi B et al. Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. Stroke. 2006;37:1319\u20131326.","DOI":"10.1161\/01.STR.0000217303.22856.38"},{"key":"ref24","unstructured":"Kusumi I, Koyama T, Yamashita I. Effect of mood stabilizing agents on agonist-induced calcium mobilization in human platelets. Journal of Psychiatry and Neuroscience. 1994;19:222\u2013225."},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Pacheco MA, Jope RS. Modulation of carbachol-stimulated AP-1 DNA binding activity by therapeutic agents for tipolar disorder in human neuroblastoma SH-Sy5Y cells. Molecular Brain Research. 1999;72:138\u2013146.","DOI":"10.1016\/S0169-328X(99)00215-6"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Suzuki K, Kusumi I, Akimoto T, Sasaki Y, Koyama T. Effects of lithium and valproate on agonist-induced platelet intracellular calcium mobilization: relevance to myosin light chain kinase. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(28):67\u201372.","DOI":"10.1016\/j.pnpbp.2003.09.021"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Akimoto T, Kusumi I, Suzuki K, Masui T, Koyama T. Effects of valproate on serotonin-induced intracellular calcium mobilization in human platelets. J Psychiatry Neurosci. 2007;32(1):17\u201322.","DOI":"10.1139\/jpn.0703"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Soeiro-de-Souza MG, Dias VV, Figueira ML et al. Translating neurotrophic and cellular plascticity: from pathophysiology to improved therapeutics for bipolar disorder. Acta Psychiatrica Scandinavica. 2012;126:332\u2013341.","DOI":"10.1111\/j.1600-0447.2012.01889.x"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440\u20133450.","DOI":"10.1016\/S0021-9258(19)83641-4"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Dubovsky SL, Lee C, Christiano J, Murphy J. Elevated platelet intracellular calcium concentration in bipolar depression. Biol Psychiatry. 1991;29(5):441\u2013450.","DOI":"10.1016\/0006-3223(91)90266-O"},{"key":"ref31","unstructured":"Busner J, Targum SD. The Clinical Global Impressions Scale. Applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28\u201337."},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Andreopoulos S, Wasserman M, Woo K, Li PP, Warsh JJ. Chronic lithium treatment of B lymphoblasts from bipolar disorder patients reduces transient receptor potential channel 3 levels. Pharmacogenomic Journal. 2004;4:365\u2013373.","DOI":"10.1038\/sj.tpj.6500266"},{"key":"ref33","unstructured":"Dubovsky SL. Intracellular calcium ion signaling in bipolar mood disorders: new data and directions. Internal Medicine Review. 2019;5(2):1\u201318."},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Dubovsky SL, Murphy J, Thomas M, Rademacher J. Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. Am J Psychiatry. 1992;149:118\u2013120.","DOI":"10.1176\/ajp.149.1.118"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Harrison PJ, Hall N, Mould A, Al-Juffali N, Tunbridge EM. Cellular calcium in bipolar disorder: systematic review and meta-analysis. Molecular Psychiatry. 2021;26:4106\u20134116.","DOI":"10.1038\/s41380-019-0622-y"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Yamada S, Uchida S, Naito T et al. Increase in receptor binding affinity for nimodipine in the rat brain with permanent occlusion of bilateral carotid arteries. Life Sciences. 2000;66(14):1351\u20131357.","DOI":"10.1016\/S0024-3205(00)00443-4"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Dubovsky SL, Thomas M, Hijazi A, Murphy J. Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder. EurArchPsychiatry Clin Neurosci. 1994;243:229\u2013234.","DOI":"10.1007\/BF02191579"}],"container-title":["Psychopharmacology Bulletin"],"original-title":[],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:33:50Z","timestamp":1791315230000},"score":1,"resource":{"primary":{"URL":"https:\/\/medworksmedia.com\/pb-article\/effects-of-valproate-on-intracellular-calcium-ion-signaling-implications-for-mechanistic-research\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8,12]]}},"URL":"https:\/\/doi.org\/10.64719\/pb.4550","relation":{},"ISSN":["2472-2448"],"issn-type":[{"value":"2472-2448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}